A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-27
DOI
10.1038/s41419-018-1139-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer
- (2018) Katherine Hughes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules
- (2017) Wenda Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein
- (2016) Shanshan Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors
- (2015) Philias Daka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening
- (2015) Ka-Ho Leung et al. METHODS
- Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro
- (2015) Weidong Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
- (2015) W Huang et al. ONCOGENE
- A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
- (2015) Li Lin et al. NEOPLASIA
- Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
- (2014) Chun-Yu Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)
- (2014) Haijun Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dithiaarsanes Induce Oxidative Stress-Mediated Apoptosis in HL-60 Cells by Selectively Targeting Thioredoxin Reductase
- (2014) Yaping Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
- (2013) X. Zhang et al. CANCER RESEARCH
- Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy
- (2013) Haijun Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel STAT3 Small Molecule Inhibitors via in Silico Site-Directed Fragment-Based Drug Design
- (2013) Wenying Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma
- (2013) Brent D. G. Page et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents
- (2013) Haijun Chen et al. ACS Medicinal Chemistry Letters
- Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
- (2013) Sina Haftchenary et al. ACS Medicinal Chemistry Letters
- TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
- (2012) Benjamin J. Shields et al. MOLECULAR AND CELLULAR BIOLOGY
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells
- (2011) Aiguo Liu et al. CANCER SCIENCE
- Oral administration of penta-O-galloyl- -D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition
- (2011) H.-J. Lee et al. CARCINOGENESIS
- Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2′,3′-seco-3′-nor DCP and DCK analogues
- (2011) Ying Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anti-AIDS agents 85. Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents
- (2011) Ting Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents
- (2011) Ying Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)
- (2011) Huameng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues as Potent and Selective Antitumor Agents
- (2011) Xiaoming Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression
- (2011) Katherine Hughes et al. JOURNAL OF PATHOLOGY
- A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes
- (2010) Xiaolei Zhang et al. BIOCHEMICAL PHARMACOLOGY
- An unnatural amino acid that mimics phosphotyrosine
- (2010) Jingyan Ge et al. CHEMICAL COMMUNICATIONS
- LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
- (2009) B Fuh et al. BRITISH JOURNAL OF CANCER
- Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities
- (2009) Steven Fletcher et al. CHEMBIOCHEM
- Nature: a vital source of leads for anticancer drug development
- (2009) G. M. Cragg et al. PHYTOCHEMISTRY REVIEWS
- Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening
- (2008) Wenshan Hao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
- (2008) D.-S. Shin et al. CANCER RESEARCH
- Inhibition of the Signal Transducer and Activator of Transcription-3 (STAT3) Signaling Pathway by 4-Oxo-1-Phenyl-1,4-Dihydroquinoline-3-Carboxylic Acid Esters
- (2008) Jun Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started